CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
Page 4 of 28 · 548 filings